We are live on
!
Find out more
LP
Longview Partners Portfolio holdings
AUM
$7.06B
1-Year Est. Return
3.43%
This Fund
S&P 500
This Quarter
Est. Return
-1.25%
1 Year Est. Return
-3.43%
3 Year Est. Return
+28.48%
5 Year Est. Return
+46.59%
10 Year Est. Return
+218.87%
AUM
$15.3B
AUM Growth
-$393M
(-2.5%)
Cap. Flow
-$90.1M
Cap. Flow
% of AUM
-0.59%
Top 10 Holdings %
Top 10 Hldgs %
50.11%
Holding
26
New
1
Increased
1
Reduced
24
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CDW
CDW
|
+$514M |
| 2 |
Moody's
MCO
|
+$51.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Express
AXP
|
+$80.3M |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$75.9M |
| 3 |
W.W. Grainger
GWW
|
+$58.4M |
| 4 |
Aon
AON
|
+$48.8M |
| 5 |
L3Harris
LHX
|
+$41.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.81% |
| 2 | Financials | 24.28% |
| 3 | Technology | 16.34% |
| 4 | Industrials | 9.9% |
| 5 | Communication Services | 8.39% |
Similar funds
IGAM
NAMA
RPI
MNA
CWM
SC
OCA
DE
Longview Partners's Q1 2022 Portfolio in Review
As of Q1 2022, Longview Partners held 26 positions worth $15.3B, down 2.5% from $15.7B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Trading was light in Q1 2022: portfolio turnover was 3.8%. Longview Partners opened 1 new position and made no exits, leaving the 26-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 31% a quarter earlier, followed by Financials and Technology.
- Longview Partners's largest Q1 2022 buy was Moody's: 152,195 shares worth $51.4M.
- Longview Partners added most to CDW in Q1 2022, an estimated $514M increase.
- Longview Partners's biggest Q1 2022 reduction was American Express, cutting an estimated $80.3M.
- Longview Partners's ten largest holdings make up 50% of its $15.3B portfolio in Q1 2022.
- Longview Partners opened 1 new position and closed 0 in Q1 2022.
- Longview Partners's portfolio value fell 2.5% quarter-over-quarter to $15.3B.
Based on Longview Partners's 13F filing for Q1 2022, filed 13 May 2022.